Psilocybin for Methamphetamine Use Disorder

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This trial tests whether psilocybin-assisted treatment can help adults stop using methamphetamine. Participants receive a single oral dose of psilocybin during a supervised session, paired with brief cognitive behavioral therapy, and are followed for up to six months. The study is supported by the HEAL Initiative (https://www.nih.gov/heal).
Epistemonikos ID: 2459cfc2045d4d39bdd433d60894c80e27b31530
First added on: Aug 19, 2026